EBERINI, IVANO
 Distribuzione geografica
Continente #
EU - Europa 16.424
NA - Nord America 10.887
AS - Asia 6.621
SA - Sud America 731
AF - Africa 105
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 6
Totale 34.845
Nazione #
US - Stati Uniti d'America 10.620
IT - Italia 4.698
GB - Regno Unito 4.227
CN - Cina 2.714
DE - Germania 2.460
SE - Svezia 1.613
SG - Singapore 1.509
RU - Federazione Russa 837
IN - India 682
BR - Brasile 541
IE - Irlanda 434
FR - Francia 406
TR - Turchia 355
UA - Ucraina 346
KR - Corea 291
DK - Danimarca 251
NL - Olanda 243
FI - Finlandia 241
JP - Giappone 215
ID - Indonesia 207
HK - Hong Kong 204
CA - Canada 169
VN - Vietnam 123
CH - Svizzera 106
EU - Europa 105
BE - Belgio 89
CO - Colombia 79
ES - Italia 75
MX - Messico 73
AU - Australia 62
PL - Polonia 62
AT - Austria 55
GR - Grecia 53
AE - Emirati Arabi Uniti 47
CZ - Repubblica Ceca 46
PT - Portogallo 42
TW - Taiwan 40
PH - Filippine 37
AR - Argentina 36
RO - Romania 34
PK - Pakistan 31
IR - Iran 30
IL - Israele 27
EG - Egitto 25
PE - Perù 23
NO - Norvegia 22
EC - Ecuador 19
NG - Nigeria 19
SC - Seychelles 19
TH - Thailandia 16
HU - Ungheria 13
UZ - Uzbekistan 12
CL - Cile 10
HR - Croazia 10
IQ - Iraq 10
SI - Slovenia 10
SK - Slovacchia (Repubblica Slovacca) 10
BD - Bangladesh 9
MY - Malesia 9
NZ - Nuova Zelanda 9
TN - Tunisia 9
VE - Venezuela 8
BG - Bulgaria 7
AL - Albania 6
AZ - Azerbaigian 6
CR - Costa Rica 6
PA - Panama 6
PY - Paraguay 6
ZA - Sudafrica 6
BO - Bolivia 5
GE - Georgia 5
KW - Kuwait 5
LU - Lussemburgo 5
MZ - Mozambico 5
SA - Arabia Saudita 5
AO - Angola 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LV - Lettonia 4
MA - Marocco 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
IS - Islanda 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
RS - Serbia 3
BS - Bahamas 2
CY - Cipro 2
HN - Honduras 2
IM - Isola di Man 2
JM - Giamaica 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
MW - Malawi 2
OM - Oman 2
PS - Palestinian Territory 2
Totale 34.923
Città #
Southend 3.732
Milan 1.636
Frankfurt am Main 1.062
Singapore 1.044
Chandler 989
Seattle 603
Fairfield 598
Wilmington 558
Ashburn 541
Ann Arbor 534
Princeton 479
Council Bluffs 465
Beijing 449
Dearborn 431
Dublin 421
Woodbridge 341
Cambridge 309
Houston 292
Redwood City 260
Nanjing 248
Jacksonville 238
Rome 229
Santa Clara 216
Grafing 208
Des Moines 180
Bengaluru 164
Hanover 163
Mountain View 161
Redmond 160
Boardman 157
Shanghai 154
Jakarta 151
Hong Kong 137
Berlin 121
Jinan 120
Guangzhou 103
Serra 99
Shenyang 99
Sunnyvale 97
Phoenix 94
Medford 91
Istanbul 87
Somerville 87
Sakarya 86
Hebei 82
Helsinki 81
Toronto 79
Andover 77
Nanchang 75
Bogotá 73
Roxbury 73
Los Angeles 67
Brussels 64
Florence 63
Tokyo 63
Changsha 62
Naples 61
Dong Ket 59
New York 57
São Paulo 55
San Diego 48
Bologna 47
Zhengzhou 45
Bühl 44
Falls Church 44
Tianjin 44
Turin 44
Warsaw 44
Fuzhou 42
Hangzhou 42
Nuremberg 42
Boston 38
Jiaxing 37
Seoul 35
Al Ain City 34
Fremont 33
Haikou 33
Kunming 33
Vienna 32
Bitonto 31
Ottawa 31
Padova 31
Auburn Hills 29
Silver Spring 29
Athens 28
London 28
Cinisello Balsamo 27
Wuhan 27
Chicago 25
Hefei 25
Ningbo 25
Verona 25
Paris 24
Central District 23
Hyderabad 23
Taiyuan 23
Amsterdam 22
Bari 21
Catania 21
Rho 21
Totale 20.785
Nome #
Farmacologia, farmacocinetica e farmacodinamica nel neonato 1.574
Glatiramer acetate : a complex drug beyond biologics 669
With or without you - Proteomics with or without major plasma/serum proteins 527
A novel SEMA3G mutation in two siblings affected by syndromic GnRH deficiency 449
Body composition and metabolic changes during a 520-day mission simulation to Mars 422
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5) : probing critical residues for substrate translocation 330
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 329
Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand 316
SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure 301
Acute-phase proteins before cerebral ischemia in stroke-prone rats : identification by proteomic 289
Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid 286
Serological follow-up of SARS-CoV-2 asymptomatic subjects 279
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 259
A promiscuous recognition mechanism between GPR17 and SDF-1 : molecular insights 255
Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity 249
Proteins of rat serum, urine, and cerebrospinal fluid : VI. Further protein identifications and interstrain comparison 239
Strategies for proteomics with incompletely characterized genomes : the proteome of Bos taurus serum 234
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 230
Ruolo dei media nella comunicazione scientifica e nella percezione del rischio da parte della società civile 226
Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems 225
In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth : hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells 225
Bacterial production, characterization and protein modeling of a novel monofuctional isoform of FAD synthase in humans: an emergency protein? 222
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 216
Inhibition of Pancreatic α-amylase by Resveratrol Derivatives : Biological Activity and Molecular Modelling Evidence for Cooperativity between Viniferin Enantiomers 211
In silico description of LAT1 transport mechanism at an atomistic level 208
Identification of small molecules uncoupling the Notch : Jagged interaction through an integrated high-throughput screening 207
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis 205
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 204
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 203
Molecular mechanism of inhibition of the mitochondrial carnitine/acylcarnitine transporter by omeprazole revealed by proteoliposome assay, mutagenesis and bioinformatics 203
Comparison of teratogenic potency of azoles using in silico and in vitro methods 200
Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach 199
Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke 198
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach 198
Strategic single point mutation yields a solvent- and salt-stable transaminase from Virgibacillus sp. in soluble form 196
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex 195
2,4-Furfurylidene-D-sorbitol and its tetra-methyl ether: Synthesis, conformational studies, and radical scavenging activity 195
Il ruolo dei ricercatori nella comunicazione della scienza tra pandemia e infodemia 195
Computational and experimental approaches for assessing the interactions between the model calycin beta-lactoglobulin and two antibacterial fluoroquinolones 192
Deciphering and modelling remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties 191
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 191
In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date 189
A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis 188
Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays 187
Urea and guanidinium chloride denature Protein L in different ways in molecular dynamics simulations 184
Development of an adverse outcome pathway for cranio-facial malformations: A contribution from in silico simulations and in vitro data 184
Characterization of in vivo activity of a novel Lecithin:cholesterol acyltransferase inhibitor 182
Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocyte 181
Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein 179
Comparison of Protein Design Tools For Engineering Non-heme Iron Dependent Dioxygenases 178
All-purpose containers? Lipid-binding protein : drug interactions 176
A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies 173
Perivascular carotid collar placement induces neointima formation and outward arterial remodeling in mice independent of apolipoprotein E deficiency or Western-type diet feeding 173
Biosynthesis of flavin cofactors in man: implications in health and disease 172
In silico prioritization of endocrine active substances (EAS) and their in vitro validation 172
Predicting estrogen receptor binding of chemicals using a suite of in silico methods – Complementary approaches of (Q)SAR, molecular docking and molecular dynamics 172
A novel therapeutic approach targeted notch in multiple myeloma based on small molecules uncoupling receptor-ligand interaction 171
Targeting the Notch pathway in multiple myeloma through small molecules uncoupling Notch-Jag interaction 170
Proteomic methods for the analysis of white lupin storage proteins 167
An in silico structural approach to critical quality attributes assessment of biopharmaceutical products 167
rHDL modelling and the anchoring mechanism of LCAT activation 167
UNRAVELLING THE STRUCTURAL MODIFICATION OF BETA-LACTOGLOBULIN AFTER ADSORBTION ON POLYSTYRENE NANOPARTICLES 162
Redox regulation of cyclophilin a by glutathionylation 162
What changes in pharmacokinetics and pharmacodynamics occur in pediatric patients? 161
Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients 160
Recombinant S. cerevisiae expressing old yellow enzymes from non-conventional yeasts : an easy system for selective reduction of activated alkenes 160
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 160
Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells 158
GPR17 molecular modelling: interactions with non-conventional pro-inflammatory ligands 158
Effect of genotype and diet on carotid lesions induced by perivascular collar placement in apoE-/- and wild-type mice 157
A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites 157
Computational modelling of the LCAT::rHDL complex and bases of LCAT pharmacological activation 157
Stereoselective reduction of aromatic ketones by a new ketoreductase from Pichia glucozyma 156
Stereoselective reduction of aromatic ketones by a new ketoreductase from Pichia glucozyma 156
A novel Notch-targeted therapeutic approach in multiple myeloma based on small molecules disrupting Notch-Jagged interaction 156
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 156
Simulation of urea-induced protein unfolding: a lesson from bovine beta-lactoglobulin 155
Computational studies on bovine beta-lactoglobulin 155
Development of an integrated system biology model for predicting mixtures of chemicals: the case of the azole fungicides 153
Zea mays L. protein changes in response to potassium dichromate treatments 152
Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient 151
The influence of sex hormones on vascular responses in the aorta of streptozotocin-diabetic male rats 148
Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats 147
Analysis of Lupinus albus storage proteins by two-dimensional electrophoresis and mass spectrometry 147
Gender proteomics. II. Which proteins in sexual organs 147
Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini 146
Inflammatory serum proteome pattern in mice fed a high-fat diet 146
Inhibition of pancreatic α-amylase by resveratrol-derived viniferins relates to their geometrical features and implies co-operative binding 146
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 145
Modellng Molecolare e meccanismo di interazione del complesso LCAT-rHDL 145
What if? Mouse proteomics after gene inactivation 145
Subcellular localization of soybean 7S globulin in HepG2 cells and LDL receptor up-regulation by its alpha' constituent subunit 144
Gpr17-modulating compounds, diagnostic and therapeutic uses thereof 144
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 144
Structural insights into the desymmetrization of bulky 1,2-dicarbonyls through enzymatic monoreduction 144
Redox options in two-dimensional electrophoresis 142
Distinguishing mode of action of compounds inducing craniofacial malformations in zebrafish embryos to support dose-response modeling in combined exposures 142
New aspects of altitude adaptation in Tibetans : A proteomic approach 140
Presence of constitutive endothelial nitric oxide synthase immunoreactivity in urothelial cells of hamster proximal urethra 140
Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins 138
Totale 21.356
Categoria #
all - tutte 110.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.694 0 0 0 0 0 0 0 0 666 588 250 190
2020/20214.408 262 379 312 170 365 392 261 269 616 418 599 365
2021/20224.655 482 306 337 252 397 328 313 215 369 496 283 877
2022/20234.795 574 419 395 431 474 860 196 324 498 129 301 194
2023/20244.585 179 278 419 463 804 250 350 340 176 344 397 585
2024/20255.366 438 838 365 835 652 383 437 988 430 0 0 0
Totale 36.832